Výsledky vyhledávání

Akademický článek

Cancer-associated fibroblast-derived exosome microRNA-21 promotes angiogenesis in multiple myeloma.

Autor: Miaomiao S; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.; BGI College, Zhengzhou University, Zhengzhou, People's Republic of China.; Henan Province Key Laboratory of Tumor Pathology, Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Xiaoqian W; BGI College, Zhengzhou University, Zhengzhou, People's Republic of China.; Henan Province Key Laboratory of Tumor Pathology, Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Yuwei S; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.; Henan Province Key Laboratory of Tumor Pathology, Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Chao C; Henan Province Key Laboratory of Tumor Pathology, Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Chenbo Y; Henan Province Key Laboratory of Tumor Pathology, Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Yinghao L; BGI College, Zhengzhou University, Zhengzhou, People's Republic of China.; Henan Province Key Laboratory of Tumor Pathology, Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Yichen H; BGI College, Zhengzhou University, Zhengzhou, People's Republic of China.; Henan Province Key Laboratory of Tumor Pathology, Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Jiao S; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Kuisheng C; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China. chenksh2002@163.com.; Henan Province Key Laboratory of Tumor Pathology, Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China. chenksh2002@163.com.

Publikováno v: Scientific reports [Sci Rep] 2023 Jun 14; Vol. 13 (1), pp. 9671. Date of Electronic Publication: 2023 Jun 14.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Management and Prognosis of Interstitial Lung Disease With Lung Cancer (ILD-LC): A Real-World Cohort From Three Medical Centers in China.

Autor: Xiaohong X; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China., Liqiang W; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China., Na L; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Xinqing L; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China., Yinyin Q; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China., Ming L; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China., Ming O; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China., Qian H; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China., Qun L; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China., Shiyue L; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China., Chunyan L; Department of Respiratory and Critical Care Medicine, The First Medical Center of PLA General Hospital, Beijing, China., Xiaoqian W; Department of Respiratory and Critical Care Medicine, The First Medical Center of PLA General Hospital, Beijing, China., Shuanying Y; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Wei H; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Mei L; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Ping W; Department of Respiratory and Critical Care Medicine, The Eighth Medical Center of PLA General Hospital, Beijing, China., Chengzhi Z; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of the Respiratory Health, Guangzhou Medical University, Guangzhou, China.

Publikováno v: Frontiers in molecular biosciences [Front Mol Biosci] 2021 Mar 31; Vol. 8, pp. 660800. Date of Electronic Publication: 2021 Mar 31 (Print Publication: 2021).

Zobrazit plný text záznamu

Akademický článek

DEAD-box Helicase 27 Promotes Hepatocellular Carcinoma Progression Through ERK Signaling.

Autor: Xiaoqian W; 12476The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China., Bing Z; 12476The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China., Yangwei L; 12476The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China., Yafei Z; 377327China-US (Henan) Hormel Cancer Institute, Zhengzhou, China., Tingting Z; 12476The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China., Yi W; 12476The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China., Qingjun L; 12476The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China., Suxia L; The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China., Ling Z; 12476The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China., Bo W; 12476Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative diseases, Tianjin Neurosurgical Institute, Tianjin, China., Peng Z; 12476The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Publikováno v: Technology in cancer research & treatment [Technol Cancer Res Treat] 2021 Jan-Dec; Vol. 20, pp. 15330338211055953.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání